FARABURSEN
UNII J7AP97D44Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Farabursen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J7AP97D44Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2953012-32-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
J7AP97D44Q
CAS Registry Number
2953012-32-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FARABURSEN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13569
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
MN-145
Identifier assigned by the United States Adopted Names Council.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Farabursen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FARABURSEN

Common Names & Synonyms

FARABURSEN [INN]
FARABURSEN [USAN]
RNA, (P-THIO)((2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)A-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)G-CM-(2'-DEOXY-2'-FLUORO)A-(2'-DEOXY-2'-FLUORO)C-(2'-DEOXY-2'-FLUORO)U-UM-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)U-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)A)

Technical Codes

RGLS8429
RGLS-8429